StockWatch
·

InMed Pharmaceuticals Inc. Q1 FY26 Results

INMQ1 FY26 Results
MetricValue ($ M)Q1 FY25
Revenue1.1211.1%
Total Income1.1211.1%
Expenditure2.853.1%
PBT-1.733.0%
Net Profit-1.733.0%
OPM
NPM
EPS-0.4483.8%
View full financials

Informational and educational content only. Not investment advice.